WEALTHINK AI-INNOVATION CAPITAL LIMITED Wealthink AI-Innovation Capital Limited Share Price
Equities
1140
KYG9496A1022
Investment Management & Fund Operators
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.13 HKD | -3.70% |
|
-2.26% | -65.79% |
| Sales 2022 | 95.23M 12.17M 970M | Sales 2023 | 193M 24.66M 1.97B | Capitalization | 3.63B 464M 36.97B |
|---|---|---|---|---|---|
| Net income 2022 | 221M 28.24M 2.25B | Net income 2023 | 146M 18.65M 1.49B | EV / Sales 2022 | 25 x |
| Net cash position 2022 | 56.4M 7.21M 574M | Net cash position 2023 | 4.04B 516M 41.15B | EV / Sales 2023 | -2.13 x |
| P/E ratio 2022 |
10
x | P/E ratio 2023 |
19.1
x | Employees | 31 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 30.1% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | -3.70% | ||
| 1 week | -2.26% | ||
| Current month | -2.99% | ||
| 1 month | +5.69% | ||
| 3 months | -7.14% | ||
| 6 months | +11.11% | ||
| Current year | -65.79% |
1 week
0.13
0.14
1 month
0.120.15
Current year
0.110.30
1 year
0.100.53
3 years
0.100.85
5 years
0.102.72
10 years
0.104.03
| Managers | Title | Age | Since |
|---|---|---|---|
Bing Ya Qiao
CEO | Chief Executive Officer | 53 | 13/03/22 |
Bing Mei
DFI | Director of Finance/CFO | 59 | 31/12/18 |
Zhi Wei Liu
PSD | President | 57 | 31/12/07 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Zhi Wei Liu
PSD | President | 57 | 31/12/07 |
Qin Wang
CHM | Chairman | 58 | 30/05/23 |
Xiao Tian Yan
BRD | Director/Board Member | 65 | 21/04/22 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 29/04/24 | 0.13 | -3.70% | 804 000 |
| 26/04/24 | 0.135 | -0.74% | 920,000 |
| 25/04/24 | 0.136 | -1.45% | 0 |
| 24/04/24 | 0.138 | +3.76% | 4,024,000 |
| 23/04/24 | 0.133 | 0.00% | 0 |
Delayed Quote Hong Kong S.E., April 29, 2024 at 09:08 am
More quotes
Wealthking Investments Ltd, formerly OP Financial Ltd, is an investment holding company principally engaged in the investment in listed and unlisted enterprises. The investment objective of the Company is to achieve earnings in the form of medium to long term capital appreciation through investing in a diversified portfolio of global investments in enterprises. Its investment strategy covers long-term core holding, mid-term private equity and venture capital, and short-term arbitrage opportunities, with returns generated from interests, dividends and capital appreciation. Its portfolios mainly include medical and health, financial services and Technology, Media, Telecom (TMT).
Calendar
20/06/2024
- Q4 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -65.79% | 181M | |
| -6.07% | 113B | |
| +20.42% | 63.85B | |
| +5.23% | 61.9B | |
| +10.59% | 42.86B | |
| +9.77% | 40.84B | |
| +18.63% | 34.58B | |
| +5.43% | 25.46B | |
| -4.15% | 22.13B | |
| +2.47% | 18.61B |
- Stock Market
- Equities
- 1140 Stock
